Antiprotozoal drugs compared
Compare all 3 Antiprotozoal drugs side by side, used for conditions such as leishmaniasis, visceral, pneumonia, pneumocystis, trypanosomiasis. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores.
1 of 3 drugs in this class carry a pharmaranks safety score, ranging 66–66 out of 100 — computed from FDA recall records, not from reviews.
Full ranking · 3 drugs
Frequently asked questions
What is the Antiprotozoal drug class?
Antiprotozoal is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 3 Antiprotozoal products, each independently rated.
Are all Antiprotozoal drugs the same?
No. Antiprotozoal drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.
What conditions do Antiprotozoal drugs treat?
Per NIH RxClass drug-classification data, Antiprotozoal drugs are used for conditions including leishmaniasis, visceral, pneumonia, pneumocystis, trypanosomiasis, cryptosporidiosis, diarrhea, giardiasis.
Sources: the Antiprotozoal class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class). Ratings are pharmaranks’ independent FDA recall-safety analysis.